These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33594807)

  • 1. Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.
    Fung SYH; Chan KCA; Wong EWY; Ng CWK; Cho R; Yeung ZWC; Lam JWK; Chan JYK
    Head Neck; 2021 Jun; 43(6):1812-1822. PubMed ID: 33594807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
    Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
    Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of DNA methylation levels of
    Grossi I; Assoni C; Lorini L; Smussi D; Gurizzan C; Grisanti S; Paderno A; Mattavelli D; Piazza C; Pelisenco IA; De Petro G; Salvi A; Bossi P
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38299234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
    Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
    PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
    Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
    Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.
    Hayashi M; Guerrero-Preston R; Sidransky D; Koch WM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1017-26. PubMed ID: 26304463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma.
    Longo AL; Rettori MM; de Carvalho AC; Kowalski LP; Carvalho AL; Vettore AL
    Head Neck; 2014 May; 36(5):631-7. PubMed ID: 23595968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
    Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
    Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
    Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
    Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
    Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
    Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
    Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
    Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.
    Guerrero-Preston R; Michailidi C; Marchionni L; Pickering CR; Frederick MJ; Myers JN; Yegnasubramanian S; Hadar T; Noordhuis MG; Zizkova V; Fertig E; Agrawal N; Westra W; Koch W; Califano J; Velculescu VE; Sidransky D
    Epigenetics; 2014 Jul; 9(7):1031-46. PubMed ID: 24786473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
    Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
    Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation.
    Misawa K; Mima M; Satoshi Y; Imai A; Mochizuki D; Ishikawa R; Kita J; Yamaguchi Y; Endo S; Misawa Y; Mineta H
    J Transl Med; 2020 Jan; 18(1):31. PubMed ID: 31969157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatment.
    Laytragoon-Lewin N; Rutqvist LE; Lewin F
    Med Oncol; 2013; 30(3):654. PubMed ID: 23824644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
    Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
    Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index.
    Langevin SM; Stone RA; Bunker CH; Grandis JR; Sobol RW; Taioli E
    Carcinogenesis; 2010 May; 31(5):864-70. PubMed ID: 20197299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.